Maximus: A Discount To Peers, Even If The Recent Contract Change Is Permanent

Maximus cut fiscal 2026 adjusted EPS guidance to $7.90-$8.20 after the VA paused performance incentive payments in its medical exam program from July 1 through Dec. 31, 2026. At $55.18, MMS trades at 6.9x the $8.05 guidance average. Without the incentives, our math puts annual adjusted EPS near $7, or 7.9x, still below every peer. MMS trades at 8.2x trailing earnings against 11.5x for Leidos and 12x for Booz Allen, with a 15% trailing free cash flow yield and the lowest leverage in its peer group.

Seeking Alpha • Sep 24, 2026

Can Maximus Weather the VA Contract Hit and Rebuild Earnings Momentum?

Maximus faces an earnings reset as paused VA incentives cut profit and cash-flow guidance, testing whether service and tech gains can rebuild momentum.

Zacks Investment Research • Aug 12, 2026

Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?

Maximus trades at a deep earnings discount, but federal procurement delays and weak award conversion cloud the timing of a recovery.

Zacks Investment Research • Aug 12, 2026

Maximus Q3 Earnings Call Highlights

Maximus NYSE: MMS reported fiscal 2026 third-quarter revenue of $1.28 billion, with adjusted EBITDA margin of 15.0% and adjusted diluted earnings per share of $2.22. Revenue was in line with the company's expectations, while adjusted EBITDA margin improved from 14.7% a year earlier and adjusted EPS rose from $2.16.

MarketBeat • Aug 8, 2026

Maximus, Inc. (MMS) Q3 2026 Earnings Call Transcript

Maximus, Inc. (MMS) Q3 2026 Earnings Call Transcript

Seeking Alpha • Aug 7, 2026

Maximus Q3 Earnings Beat Estimates, Increase Year Over Year

MMS beats fiscal Q3 earnings estimates but misses on revenues, while higher margins contrast with softer sales and reduced 2026 profit guidance.

Zacks Investment Research • Aug 7, 2026

Maximus (MMS) Q3 Earnings Beat Estimates

Maximus (MMS) came out with quarterly earnings of $2.22 per share, beating the Zacks Consensus Estimate of $2.2 per share. This compares to earnings of $2.16 per share a year ago.

Zacks Investment Research • Aug 6, 2026

Here's What Key Metrics Tell Us About Maximus (MMS) Q3 Earnings

While the top- and bottom-line numbers for Maximus (MMS) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research • Aug 6, 2026

Here's Why Maximus (MMS) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Jul 23, 2026

Maximus (MMS) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Maximus (MMS) have what it takes?

Zacks Investment Research • Jul 23, 2026